COMPARATIVE EVALUATION OF THE RELEASE PROPERTIES OF VERAPAMIL HCL AND CARBAMAZEPINE FROM MICROCRYSTALLINE CELLULOSE II PELLETS
Keywords:Extrusion-spheronization, Microcrystalline cellulose II, Verapamil HCl, Carbamazepine
Objective: To study microcrystalline cellulose II (MCCII) as new pelletization aid for a high and low solubility drugs such as verapamil. HCl and carbamazepine, respectively.
Methods: Approximately, 30 g of MCCII and drug mixtures were hydrated passed through a # 20 mesh sieved and spheronizated at a frequency of 6 Hz and residence time of 480 s. A microscopy analysis was used to evaluate the shape and size descriptors. Pellets properties such as compressibility, friability, density, flowability and product yield were also evaluated. Drug release properties were tested according to the USP specifications and compared to those of MCCI.
Results: The wetting level of the excipients depended on drug loading and drug solubility. Thus, a high drug loading (>50%) rendered pellets having a low yield, flowability and caused a detriment on size descriptors. Likewise, the regular morphology and strength of MCCII-based pellets was highly affected by increasing drug loads. Verapamil. HCl pellets were less friable and compressible and showed better flowability than carbamazepine pellets. Regardless of drug loading and drug solubility, MCCII-based pellets released more than 80% of verapamil. HCl within 10 min, whereas released more than 75% of carbamazepine within 15 min. Conversely, MCCI pellets had a satisfactory verapamil. HCl release, but ~30% carbamazepine release within 1h.
Conclusion: MCCII proved to be a better excipient than MCCI to yield beads having optimal pellet characteristics and rendered an immediate release profile for verapamil. HCl and carbamazepine.
Tubati VP, Murthy GK, Rao SV. Formulation development and statistical optimization of ivabradine hydrochloride floating pulsatile pellets by fluidized bed coating technique. Asian J Pharm Clin Res 2016,9:159-66.
Krishna V, Reddy S. Formulation and evaluation of enteric coated pellets of rifampicin and isoniazid with improved rifampicin stability. Pharm Clin Res 2014;7:154-6.
Abdul S, Chadewar AV, Jaiswal SB. A flexible technology for modified-release drugs: Multiple-unit pellet system (MUPS). J Controlled Release 2010,147:2-16.
Verheyen P, Steffens KJ, Kleinebudde P. Use of crospovidone as pelletization aid as an alternative to microcrystalline cellulose: effects on pellet properties. Drug Dev Ind Pharm 2009;35:1325-32.
Rojas J, Kumar V. Evaluation of the disintegration properties of microcrystalline cellulose II and commercial disintegrants. Pharmazie 2012;67:1-7.
Deshmane SV, Channawar MA, Chandewar AV, Josh UM. Chitosan-based sustained release mucoadhesive buccal patches containing verapamil. HCl Int J Pharm Pharm Sci 2009;1:216-39.
Ono M, Tozuka Y, Oguchi T, Yamamura S, Yamamoto K. Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine. Int J Pharm 2002;239:1-12.
Mascia S, Patel MJ, Rough SL, Martin PJ, Wilson DI. Liquid phase migration in the extrusion and squeezing of microcrystalline cellulose pastes. Eur J Pharm Sci 2006;29:22-34.
Bains D, Boutell SL, Newton JM. The influence of moisture content on the preparation of spherical granules of barium sulphate and microcrystalline cellulose. Int J Pharm 1991;69:233-7.
Amidon GE, Houghton ME. The effect of moisture on the mechanical and powder flow properties of microcrystalline cellulose. Pharm Res 1995;12:923-9.